Φορτώνει......

Imipenem-cilastatin as initial therapy for febrile cancer patients.

Imipenem-cilastatin was used to treat 79 febrile episodes in 71 cancer patients, most of whom had neutropenia. The overall response rate was 67%, and 76% of the 45 documented infections responded. The response rates for septicemias and pneumonias were 79 and 62%, respectively. Only 1 of the 17 infec...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Bodey, G P, Alvarez, M E, Jones, P G, Rolston, K V, Steelhammer, L, Fainstein, V
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 1986
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC180520/
https://ncbi.nlm.nih.gov/pubmed/3532942
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!